Gene: PCYT2
Official Full Name: phosphate cytidylyltransferase 2, ethanolamineprovided by HGNC
Gene Summary: This gene encodes an enzyme that catalyzes the formation of CDP-ethanolamine from CTP and phosphoethanolamine in the Kennedy pathway of phospholipid synthesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35749 | PCYT2 Knockout cell line (HeLa) | Human | PCYT2 | 1:3~1:6 | Negative | Online Inquiry |
KO35750 | PCYT2 Knockout cell line (HCT 116) | Human | PCYT2 | 1:2~1:4 | Negative | Online Inquiry |
KO35751 | PCYT2 Knockout cell line (HEK293) | Human | PCYT2 | 1:3~1:6 | Negative | Online Inquiry |
KO35752 | PCYT2 Knockout cell line (A549) | Human | PCYT2 | 1:3~1:4 | Negative | Online Inquiry |
PCYT2 Gene Knockout Cell Lines are genetically engineered cell models designed to lack the expression of the PCYT2 gene, which encodes a key enzyme in the phospholipid biosynthesis pathway. This genetic modification facilitates the study of lipid metabolism, membrane dynamics, and associated cellular processes. By effectively silencing the PCYT2 gene, these knockout cells allow researchers to investigate the functional consequences of diminished phosphatidylcholine production, a crucial component of cell membranes.
The primary mechanism at play in PCYT2 knockout cell lines is the disruption of the CDP-choline pathway, leading to altered lipid homeostasis. This alteration invites studies on the impact that reduced phospholipid levels have on cellular functions such as proliferation, apoptosis, and signal transduction. Scientists can leverage these cell lines to explore various research avenues, from understanding the cell's response to metabolic stress to investigating the role of phospholipids in disease models, including cancer and neurodegenerative disorders.
In clinical and research settings, PCYT2 Gene Knockout Cell Lines offer significant advantages over traditional cell lines, including enhanced specificity in studying targeted metabolic pathways and the ability to model diseases associated with disrupted lipid metabolism. Their precision enables the identification of potential therapeutic targets, advancing our understanding of lipid-related diseases and facilitating drug discovery.
Researchers, clinicians, and pharmaceutical developers will find these knockout cell lines invaluable due to their robustness in providing insights into complicated biological processes. By offering a clear view into lipid metabolism's role in health and disease, these cell lines are essential tools for developing innovative strategies for therapeutic interventions.
As a leader in biotechnology, our company is dedicated to developing high-quality, genetically modified cell lines that empower researchers in their quest for knowledge and discovery. With our expertise and commitment to precision, we strive to support groundbreaking research that addresses today's critical health challenges.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.